H.R. 1956, The Patient Protection and Innovative Biologic Medicines Act of 2007 (3 wiki edits)
- This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
H.R. 1956 would amend the Public Health Service Act to provide for the approval of similar biological products.